BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 27890919)

  • 1. Human γδT-cell subsets and their involvement in tumor immunity.
    Wu D; Wu P; Qiu F; Wei Q; Huang J
    Cell Mol Immunol; 2017 Mar; 14(3):245-253. PubMed ID: 27890919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The origin and fate of γδT cell subsets.
    Kisielow J; Kopf M
    Curr Opin Immunol; 2013 Apr; 25(2):181-8. PubMed ID: 23562386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-delta (γδ) T cells: friend or foe in cancer development?
    Zhao Y; Niu C; Cui J
    J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effects of gammadelta T cells expanded ex vivo by a third generation bisphosphonate for cancer immunotherapy.
    Sato K; Kimura S; Segawa H; Yokota A; Matsumoto S; Kuroda J; Nogawa M; Yuasa T; Kiyono Y; Wada H; Maekawa T
    Int J Cancer; 2005 Aug; 116(1):94-9. PubMed ID: 15756684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging Protumor role of γδ T lymphocytes: implications for cancer immunotherapy.
    Rei M; Pennington DJ; Silva-Santos B
    Cancer Res; 2015 Mar; 75(5):798-802. PubMed ID: 25660949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Responsiveness of Innate-like IL-17- and IFN-γ-Producing γδ T Cells to Homeostatic Cytokines.
    Corpuz TM; Stolp J; Kim HO; Pinget GV; Gray DH; Cho JH; Sprent J; Webster KE
    J Immunol; 2016 Jan; 196(2):645-54. PubMed ID: 26673141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. γδT Cells and Related Diseases.
    Lu H; Li DJ; Jin LP
    Am J Reprod Immunol; 2016 Jun; 75(6):609-18. PubMed ID: 26833725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology. Now presenting: gammadelta T cells.
    Modlin RL; Sieling PA
    Science; 2005 Jul; 309(5732):252-3. PubMed ID: 16002604
    [No Abstract]   [Full Text] [Related]  

  • 9. Potent Bidirectional Cross-Talk Between Plasmacytoid Dendritic Cells and γδT Cells Through BTN3A, Type I/II IFNs and Immune Checkpoints.
    Girard P; Ponsard B; Charles J; Chaperot L; Aspord C
    Front Immunol; 2020; 11():861. PubMed ID: 32435249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [GammadeltaT cell therapy].
    Tanaka Y; Okamura H
    Nihon Rinsho; 2012 Dec; 70(12):2147-51. PubMed ID: 23259388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-17A-producing gammadeltaT cells promote CTL responses against Listeria monocytogenes infection by enhancing dendritic cell cross-presentation.
    Xu S; Han Y; Xu X; Bao Y; Zhang M; Cao X
    J Immunol; 2010 Nov; 185(10):5879-87. PubMed ID: 20956351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Mycobacterium tuberculosis antigen and anti-TCRγδ antibody on IL-17 production of human γδT cells in polarization culture].
    Chen L; Xia H; Wang H; Sheng L; Xu Z; Sun Y; Tang J; Li B
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):226-30. PubMed ID: 25652865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGN2: An Antitumor Effector Molecule of γδT Cells.
    Chen J; Fan Y; Cui B; Li X; Yu Y; Du Y; Chen Q; Feng Y; Zhang P
    J Immunother; 2018 Apr; 41(3):118-124. PubMed ID: 29401165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells.
    Himoudi N; Morgenstern DA; Yan M; Vernay B; Saraiva L; Wu Y; Cohen CJ; Gustafsson K; Anderson J
    J Immunol; 2012 Feb; 188(4):1708-16. PubMed ID: 22250090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the role of Toll-like receptors in modulation of T cell responses.
    Kulkarni R; Behboudi S; Sharif S
    Cell Tissue Res; 2011 Jan; 343(1):141-52. PubMed ID: 20680345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New insights into cytotoxic effector cells].
    Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
    Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. gammadelta T cells: novel initiators of adaptive immunity.
    Moser B; Eberl M
    Immunol Rev; 2007 Feb; 215():89-102. PubMed ID: 17291281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation.
    Kress E; Hedges JF; Jutila MA
    Mol Immunol; 2006 May; 43(12):2002-11. PubMed ID: 16423401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of new potential antigen recognized by γδT cells in hepatocellular carcinoma.
    Xi X; Guo Y; Zhu M; Qiu F; Lei F; Li G; Du B
    Cancer Immunol Immunother; 2021 Jul; 70(7):1917-1927. PubMed ID: 33399933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tandem-epitope peptide: a novel stimulator for gammadeltaT cells in tumor immunotherapy.
    He X; Chen H; Wu D; Cui L; He W
    Cancer Lett; 2010 Feb; 288(1):86-93. PubMed ID: 19665289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.